Company · CIK 0000874015 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
IONIS PHARMACEUTICALS INC · IONS
Insider activity reported against this company. All insider holders · Files at: AKCA, RGLS. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 15, 2018 SForm 4 → | Feb 16, 6:00 pm EST | Joseph Klein IIIDirector | 3,000 | $48.99 | $146,984 | 9,939 | −23.2% | plan? |
| Feb 15, 2018 MForm 4 → | Feb 16, 6:00 pm EST | Joseph Klein IIIDirector | 3,000 | $35.53 | $106,590 | 11,539 | — | plan? |
| Feb 3, 2018 MForm 4/A → | Feb 5, 9:06 pm EST | Joseph LoscalzoDirector | 937 | — | — | 7,752 | — | plan? |
| Feb 1, 2018 SForm 4/A → | Feb 1, 7:58 pm EST | C Frank BennettSVP, Antisense Research | 12,500 | $52.50 | $656,260 | 19,114 | −39.5% | plan? |
| Feb 1, 2018 MForm 4/A → | Feb 1, 7:58 pm EST | C Frank BennettSVP, Antisense Research | 12,500 | $7.25 | $90,625 | 31,614 | — | plan? |
| Jan 30, 2018 SForm 4/A → | Jan 31, 4:18 pm EST | Joseph Klein IIIDirector | 3,000 | $52.86 | $158,580 | 9,939 | −23.2% | plan? |
| Jan 30, 2018 MForm 4/A → | Jan 31, 4:18 pm EST | Joseph Klein IIIDirector | 3,000 | $35.53 | $106,590 | 12,939 | — | plan? |
| Jan 29, 2018 SForm 4 → | Jan 31, 4:16 pm EST | Patrick R. O'NeilSVP Legal & General Counsel | 355 | $55.00 | $19,525 | 14,452 | −2.40% | plan? |
| Jan 29, 2018 MForm 4 → | Jan 31, 4:16 pm EST | Patrick R. O'NeilSVP Legal & General Counsel | 355 | $10.82 | $3,841 | 14,752 | — | plan? |
| Jan 29, 2018 SForm 4/A → | Jan 31, 4:15 pm EST | Stanley T CrookeChairman and CEO, Director | 11,000 | $54.12 | $595,320 | 4,128 | −72.7% | plan? |
| Jan 29, 2018 MForm 4/A → | Jan 31, 4:15 pm EST | Stanley T CrookeChairman and CEO, Director | 11,000 | $14.34 | $157,720 | 5,128 | — | plan? |
| Jan 25, 2018 SForm 4 → | Jan 29, 4:08 pm EST | Patrick R. O'NeilSVP Legal & General Counsel | 645 | $55.00 | $35,475 | 14,452 | −4.27% | plan? |
| Jan 25, 2018 MForm 4 → | Jan 29, 4:08 pm EST | Patrick R. O'NeilSVP Legal & General Counsel | 645 | $10.82 | $6,979 | 15,097 | — | plan? |
| Jan 16, 2018 SForm 4 → | Jan 17, 9:46 pm EST | Elizabeth L HougenSVP, Finance & CFO | 2,724 | $51.76 | $140,994 | 14,500 | −15.8% | plan? |
| Jan 16, 2018 SForm 4 → | Jan 17, 9:28 pm EST | Joseph Klein IIIDirector | 3,000 | $52.52 | $157,566 | 9,939 | −23.2% | plan? |
| Jan 16, 2018 MForm 4 → | Jan 17, 9:28 pm EST | Joseph Klein IIIDirector | 3,000 | $35.53 | $106,590 | 11,339 | — | plan? |
| Jan 16, 2018 SForm 4 → | Jan 17, 9:26 pm EST | Richard S GearySVP, Development | 2,723 | $51.76 | $140,942 | 16,680 | −14.0% | plan? |
| Jan 16, 2018 SForm 4 → | Jan 17, 9:25 pm EST | B Lynne ParshallDirector | 5,986 | $51.76 | $309,835 | 38,180 | −13.6% | plan? |
| Jan 16, 2018 SForm 4 → | Jan 17, 9:25 pm EST | Patrick R. O'NeilSVP, Legal & General Counsel | 2,697 | $51.76 | $139,597 | 14,452 | −15.7% | plan? |
| Jan 16, 2018 SForm 4 → | Jan 17, 9:23 pm EST | Sarah BoyceChief Business Officer | 2,196 | $51.76 | $113,665 | 8,931 | −19.7% | plan? |
| Jan 16, 2018 SForm 4 → | Jan 17, 9:22 pm EST | C Frank BennettSVP, Antisense Research | 2,696 | $51.76 | $139,545 | 19,114 | −12.4% | plan? |
| Jan 16, 2018 SForm 4 → | Jan 17, 9:21 pm EST | Brett P MoniaCOO | 2,821 | $51.76 | $146,015 | 15,783 | −15.2% | plan? |
| Jan 15, 2018 MForm 4 → | Jan 17, 9:46 pm EST | Elizabeth L HougenSVP, Finance & CFO | 6,732 | — | — | 17,224 | — | plan? |
| Jan 15, 2018 MForm 4 → | Jan 17, 9:26 pm EST | Richard S GearySVP, Development | 6,732 | — | — | 19,403 | — | plan? |
| Jan 15, 2018 MForm 4 → | Jan 17, 9:25 pm EST | B Lynne ParshallDirector | 18,339 | — | — | 44,166 | — | plan? |
| Jan 15, 2018 MForm 4 → | Jan 17, 9:25 pm EST | Patrick R. O'NeilSVP, Legal & General Counsel | 6,663 | — | — | 17,149 | — | plan? |
| Jan 15, 2018 MForm 4 → | Jan 17, 9:23 pm EST | Sarah BoyceChief Business Officer | 5,367 | — | — | 11,127 | — | plan? |
| Jan 15, 2018 MForm 4 → | Jan 17, 9:22 pm EST | C Frank BennettSVP, Antisense Research | 6,663 | — | — | 21,810 | — | plan? |
| Jan 15, 2018 SForm 4 → | Jan 17, 9:22 pm EST | Stanley T CrookeChairman and CEO, Director | 16,549 | $51.76 | $856,576 | 4,128 | −80.0% | plan? |
| Jan 15, 2018 MForm 4 → | Jan 17, 9:22 pm EST | Stanley T CrookeChairman and CEO, Director | 31,334 | — | — | 4,784 | — | plan? |
| Jan 15, 2018 MForm 4 → | Jan 17, 9:21 pm EST | Brett P MoniaCOO | 6,985 | — | — | 18,604 | — | plan? |
| Jan 8, 2018 SForm 4 → | Jan 10, 6:43 pm EST | Stanley T CrookeChairman and CEO, Director | 11,000 | $52.01 | $572,110 | 3,062 | −78.2% | plan? |
| Jan 8, 2018 MForm 4 → | Jan 10, 6:43 pm EST | Stanley T CrookeChairman and CEO, Director | 11,000 | $14.34 | $157,720 | 4,062 | — | plan? |
| Jan 3, 2018 SForm 4 → | Jan 5, 4:41 pm EST | Stanley T CrookeChairman and CEO, Director | 22,000 | $50.01 | $1,100,160 | 3,062 | −87.8% | plan? |
| Jan 3, 2018 MForm 4 → | Jan 5, 4:41 pm EST | Stanley T CrookeChairman and CEO, Director | 22,000 | $14.19 | $312,213 | 4,158 | — | plan? |
| Jan 2, 2018 SForm 4 → | Jan 2, 8:49 pm EST | Brett P MoniaSVP, Antisense Drug Discovery | 163 | $50.00 | $8,150 | 11,619 | −1.38% | plan? |
| Jan 1, 2018 JForm 4 → | Jan 2, 8:51 pm EST | B Lynne ParshallCOO, Director | 86 | $42.76 | $3,677 | 25,827 | — | plan? |
| Jan 1, 2018 JForm 4 → | Jan 2, 8:50 pm EST | Patrick R. O'NeilSVP, Legal & General Counsel | 53 | $42.76 | $2,266 | 10,486 | — | plan? |
| Jan 1, 2018 JForm 4 → | Jan 2, 8:49 pm EST | Brett P MoniaSVP, Antisense Drug Discovery | 156 | $42.76 | $6,670 | 11,782 | — | plan? |
| Jan 1, 2018 JForm 4 → | Jan 2, 8:49 pm EST | Elizabeth L HougenSVP, Finance & CFO | 100 | $42.76 | $4,276 | 10,492 | — | plan? |
| Jan 1, 2018 JForm 4 → | Jan 2, 8:48 pm EST | Richard S GearySVP, Development | 320 | $42.76 | $13,682 | 12,671 | — | plan? |
| Jan 1, 2018 JForm 4 → | Jan 2, 8:45 pm EST | Sarah BoyceChief Business Officer | 491 | $42.76 | $20,993 | 5,760 | — | plan? |
| Jan 1, 2018 JForm 4 → | Jan 2, 8:45 pm EST | C Frank BennettSVP, Antisense Research | 106 | $42.76 | $4,532 | 15,147 | — | plan? |
| Dec 29, 2017 SForm 4 → | Jan 2, 2018, 5:50 pm EST | Joseph Klein IIIDirector | 3,000 | $50.56 | $151,680 | 9,939 | −23.2% | plan? |
| Dec 29, 2017 MForm 4 → | Jan 2, 2018, 5:50 pm EST | Joseph Klein IIIDirector | 3,000 | $28.47 | $85,410 | 12,939 | — | plan? |
| Dec 15, 2017 SForm 4 → | Dec 19, 8:27 pm EST | Joseph Klein IIIDirector | 3,000 | $51.69 | $155,070 | 9,939 | −23.2% | plan? |
| Dec 15, 2017 MForm 4 → | Dec 19, 8:27 pm EST | Joseph Klein IIIDirector | 3,000 | $28.47 | $85,410 | 12,939 | — | plan? |
| Dec 15, 2017 SForm 4 → | Dec 19, 8:20 pm EST | Elizabeth L HougenSVP, Finance & CFO | 5,000 | $52.55 | $262,750 | 10,392 | −32.5% | plan? |
| Dec 15, 2017 MForm 4 → | Dec 19, 8:20 pm EST | Elizabeth L HougenSVP, Finance & CFO | 5,000 | $10.29 | $51,450 | 15,392 | — | plan? |
| Dec 4, 2017 SForm 4 → | Dec 6, 6:36 pm EST | Elizabeth L HougenSVP, Finance & CFO | 4,000 | $57.00 | $228,000 | 10,392 | −27.8% | plan? |
| Dec 4, 2017 MForm 4 → | Dec 6, 6:36 pm EST | Elizabeth L HougenSVP, Finance & CFO | 4,000 | $10.29 | $41,160 | 14,392 | — | plan? |
| Dec 1, 2017 SForm 4 → | Dec 1, 7:03 pm EST | Patrick R. O'NeilSVP, Legal & General Counsel | 1,000 | $55.50 | $55,500 | 10,433 | −8.75% | plan? |
| Dec 1, 2017 MForm 4 → | Dec 1, 7:03 pm EST | Patrick R. O'NeilSVP, Legal & General Counsel | 1,000 | $10.82 | $10,820 | 11,433 | — | plan? |
| Nov 30, 2017 SForm 4 → | Dec 1, 7:04 pm EST | Joseph Klein IIIDirector | 3,000 | $53.55 | $160,650 | 9,939 | −23.2% | plan? |
| Nov 30, 2017 MForm 4 → | Dec 1, 7:04 pm EST | Joseph Klein IIIDirector | 3,000 | $28.47 | $85,410 | 12,939 | — | plan? |
| Nov 29, 2017 SForm 4 → | Dec 1, 7:12 pm EST | Elizabeth L HougenSVP, Finance & CFO | 6,000 | $53.02 | $318,120 | 10,392 | −36.6% | plan? |
| Nov 29, 2017 MForm 4 → | Dec 1, 7:12 pm EST | Elizabeth L HougenSVP, Finance & CFO | 6,000 | $10.29 | $61,740 | 16,392 | — | plan? |
| Nov 16, 2017 SForm 4 → | Nov 17, 5:57 pm EST | Elizabeth L HougenSVP, Finance & CFO | 7,000 | $54.35 | $380,450 | 10,392 | −40.2% | plan? |
| Nov 16, 2017 MForm 4 → | Nov 17, 5:57 pm EST | Elizabeth L HougenSVP, Finance & CFO | 7,000 | $10.29 | $72,030 | 17,392 | — | plan? |
| Nov 15, 2017 SForm 4 → | Nov 17, 5:57 pm EST | Joseph Klein IIIDirector | 2,250 | $53.56 | $120,510 | 7,127 | −24.0% | plan? |
| Nov 15, 2017 MForm 4 → | Nov 17, 5:57 pm EST | Joseph Klein IIIDirector | 5,062 | $19.84 | $100,445 | 9,939 | — | plan? |
| Nov 13, 2017 SForm 4 → | Nov 14, 6:29 pm EST | Joseph Klein IIIDirector | 3,000 | $55.39 | $166,170 | 7,127 | −29.6% | plan? |
| Nov 1, 2017 SForm 4 → | Nov 3, 5:20 pm EDT | Patrick R. O'NeilSVP, Legal & General Counsel | 1,000 | $58.35 | $58,350 | 10,433 | −8.75% | plan? |
| Nov 1, 2017 MForm 4 → | Nov 3, 5:20 pm EDT | Patrick R. O'NeilSVP, Legal & General Counsel | 1,000 | $10.82 | $10,820 | 11,433 | — | plan? |
| Oct 18, 2017 SForm 4 → | Oct 20, 5:35 pm EDT | C Frank BennettSVP, Antisense Research | 12,250 | $65.00 | $796,250 | 15,041 | −44.9% | plan? |
| Oct 18, 2017 MForm 4 → | Oct 20, 5:35 pm EDT | C Frank BennettSVP, Antisense Research | 12,250 | $10.29 | $126,052 | 27,291 | — | plan? |
| Oct 18, 2017 SForm 4 → | Oct 20, 5:34 pm EDT | B Lynne ParshallCOO, Director | 16,118 | $65.00 | $1,047,670 | 25,741 | −38.5% | plan? |
| Oct 18, 2017 MForm 4 → | Oct 20, 5:34 pm EDT | B Lynne ParshallCOO, Director | 16,118 | $27.71 | $446,598 | 34,074 | — | plan? |
| Oct 13, 2017 SForm 4 → | Oct 17, 5:36 pm EDT | Stanley T CrookeChairman and CEO, Director | 16,500 | $59.46 | $981,090 | 3,062 | −84.3% | plan? |
| Oct 13, 2017 MForm 4 → | Oct 17, 5:36 pm EDT | Stanley T CrookeChairman and CEO, Director | 16,500 | $14.01 | $231,225 | 4,562 | — | plan? |
| Oct 13, 2017 MForm 4 → | Oct 17, 5:36 pm EDT | Richard S GearySVP, Development | 7,461 | $7.42 | $55,387 | 19,386 | — | plan? |
| Oct 13, 2017 SForm 4 → | Oct 17, 5:36 pm EDT | Richard S GearySVP, Development | 8,268 | $60.00 | $496,080 | 12,351 | −40.1% | plan? |
| Oct 5, 2017 SForm 4 → | Oct 6, 4:41 pm EDT | Patrick R. O'NeilSVP, Legal & General Counsel | 1,000 | $55.00 | $55,000 | 10,433 | −8.75% | plan? |
| Oct 5, 2017 MForm 4 → | Oct 6, 4:41 pm EDT | Patrick R. O'NeilSVP, Legal & General Counsel | 1,000 | $10.11 | $10,106 | 11,233 | — | plan? |
| Oct 2, 2017 SForm 4 → | Oct 4, 7:15 pm EDT | Stanley T CrookeChairman and CEO, Director | 27,500 | $52.89 | $1,454,475 | 3,062 | −90.0% | plan? |
| Oct 2, 2017 MForm 4 → | Oct 4, 7:15 pm EDT | Stanley T CrookeChairman and CEO, Director | 27,500 | $14.01 | $385,375 | 3,562 | — | plan? |
| Sep 5, 2017 SForm 4 → | Sep 7, 8:23 pm EDT | Patrick R. O'NeilSVP, Legal and General Counsel | 1,000 | $55.00 | $55,000 | 10,433 | −8.75% | plan? |
| Sep 5, 2017 MForm 4 → | Sep 7, 8:23 pm EDT | Patrick R. O'NeilSVP, Legal and General Counsel | 1,000 | $7.25 | $7,250 | 11,233 | — | plan? |
| Jul 24, 2017 SForm 4 → | Jul 26, 8:03 pm EDT | C Frank BennettSVP, Antisense Research | 10,000 | $59.29 | $592,900 | 15,041 | −39.9% | plan? |
| Jul 24, 2017 MForm 4 → | Jul 26, 8:03 pm EDT | C Frank BennettSVP, Antisense Research | 10,000 | $10.29 | $102,900 | 25,041 | — | plan? |
| Jul 20, 2017 SForm 4 → | Jul 24, 5:54 pm EDT | Stanley T CrookeChairman and CEO, Director | 11,000 | $55.35 | $608,850 | 3,062 | −78.2% | plan? |
| Jul 20, 2017 MForm 4 → | Jul 24, 5:54 pm EDT | Stanley T CrookeChairman and CEO, Director | 11,000 | $14.01 | $154,150 | 4,062 | — | plan? |
| Jul 17, 2017 SForm 4 → | Jul 18, 7:01 pm EDT | Stanley T CrookeChairman and CEO, Director | 16,500 | $52.45 | $865,425 | 3,062 | −84.3% | plan? |
| Jul 17, 2017 MForm 4 → | Jul 18, 7:01 pm EDT | Stanley T CrookeChairman and CEO, Director | 16,500 | $14.01 | $231,225 | 4,562 | — | plan? |
| Jul 3, 2017 SForm 4 → | Jul 3, 5:38 pm EDT | Brett P MoniaSVP, Antisense Drug Discovery | 309 | $51.35 | $15,867 | 11,626 | −2.59% | plan? |
| Jul 3, 2017 SForm 4 → | Jul 3, 5:34 pm EDT | Stanley T CrookeChairman and CEO, Director | 16,500 | $52.10 | $859,688 | 3,062 | −84.3% | plan? |
| Jul 3, 2017 MForm 4 → | Jul 3, 5:34 pm EDT | Stanley T CrookeChairman and CEO, Director | 16,500 | $7.94 | $131,068 | 4,562 | — | plan? |
| Jul 2, 2017 MForm 4 → | Jul 3, 5:31 pm EDT | Joseph Klein IIIDirector | 2,469 | — | — | 10,127 | — | plan? |
| Jul 1, 2017 JForm 4 → | Jul 3, 5:38 pm EDT | Brett P MoniaSVP, Antisense Drug Discovery | 163 | $40.66 | $6,627 | 11,935 | — | plan? |
| Jul 1, 2017 JForm 4 → | Jul 3, 5:38 pm EDT | B Lynne ParshallCOO, Director | 90 | $40.66 | $3,659 | 25,741 | — | plan? |
| Jul 1, 2017 JForm 4 → | Jul 3, 5:37 pm EDT | Patrick R. O'NeilSVP, Legal & General Counsel | 134 | $40.66 | $5,448 | 10,433 | — | plan? |
| Jul 1, 2017 JForm 4 → | Jul 3, 5:36 pm EDT | Elizabeth L HougenSVP, Finance & CFO | 104 | $40.66 | $4,228 | 10,392 | — | plan? |
| Jul 1, 2017 JForm 4 → | Jul 3, 5:36 pm EDT | Richard S GearySVP, Development | 196 | $40.66 | $7,968 | 13,158 | — | plan? |
| Jul 1, 2017 JForm 4 → | Jul 3, 5:35 pm EDT | Sarah BoyceChief Business Officer | 17 | $40.66 | $691 | 5,269 | — | plan? |
| Jul 1, 2017 JForm 4 → | Jul 3, 5:35 pm EDT | C Frank BennettSVP, Antisense Research | 253 | $40.66 | $10,286 | 15,041 | — | plan? |
| Jul 1, 2017 MForm 4 → | Jul 3, 5:33 pm EDT | Joseph H WenderDirector | 2,469 | — | — | 36,249 | — | plan? |
| Jul 1, 2017 MForm 4 → | Jul 3, 5:33 pm EDT | Frederick T MutoDirector | 2,469 | — | — | 7,127 | — | plan? |
| Jul 1, 2017 MForm 4 → | Jul 3, 5:32 pm EDT | Joseph LoscalzoDirector | 2,001 | — | — | 6,815 | — | plan? |
| Jul 1, 2017 MForm 4 → | Jul 3, 5:31 pm EDT | Breaux CastlemanDirector | 3,406 | — | — | 9,627 | — | plan? |
| Jul 1, 2017 MForm 4 → | Jul 3, 5:30 pm EDT | Spencer R BerthelsenDirector | 2,469 | — | — | 91,427 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2017 MForm 4 → | Dec 19, 8:20 pm EST | Elizabeth L HougenSVP, Finance & CFO | 5,000 | — | — | 0 | — | |
| Dec 4, 2017 MForm 4 → | Dec 6, 6:36 pm EST | Elizabeth L HougenSVP, Finance & CFO | 4,000 | — | — | 5,000 | — | |
| Dec 1, 2017 MForm 4 → | Dec 1, 7:03 pm EST | Patrick R. O'NeilSVP, Legal & General Counsel | 1,000 | — | — | 700 | — | |
| Nov 30, 2017 MForm 4 → | Dec 1, 7:04 pm EST | Joseph Klein IIIDirector | 3,000 | — | — | 6,000 | — | |
| Nov 29, 2017 MForm 4 → | Dec 1, 7:12 pm EST | Elizabeth L HougenSVP, Finance & CFO | 6,000 | — | — | 9,000 | — | |
| Nov 16, 2017 MForm 4 → | Nov 17, 5:57 pm EST | Elizabeth L HougenSVP, Finance & CFO | 7,000 | — | — | 15,000 | — | |
| Nov 15, 2017 MForm 4 → | Nov 17, 5:57 pm EST | Joseph Klein IIIDirector | 5,062 | — | — | 0 | — | |
| Nov 1, 2017 MForm 4 → | Nov 3, 5:20 pm EDT | Patrick R. O'NeilSVP, Legal & General Counsel | 1,000 | — | — | 1,700 | — | |
| Oct 18, 2017 MForm 4 → | Oct 20, 5:35 pm EDT | C Frank BennettSVP, Antisense Research | 12,250 | — | — | 0 | — | |
| Oct 18, 2017 MForm 4 → | Oct 20, 5:34 pm EDT | B Lynne ParshallCOO, Director | 16,118 | — | — | 74,167 | — | |
| Oct 13, 2017 MForm 4 → | Oct 17, 5:36 pm EDT | Stanley T CrookeChairman and CEO, Director | 16,500 | — | — | 904 | — | |
| Oct 13, 2017 MForm 4 → | Oct 17, 5:36 pm EDT | Richard S GearySVP, Development | 7,461 | — | — | 0 | — | |
| Oct 5, 2017 MForm 4 → | Oct 6, 4:41 pm EDT | Patrick R. O'NeilSVP, Legal & General Counsel | 1,000 | — | — | 2,700 | — | |
| Oct 2, 2017 MForm 4 → | Oct 4, 7:15 pm EDT | Stanley T CrookeChairman and CEO, Director | 27,500 | — | — | 2,404 | — | |
| Sep 5, 2017 MForm 4 → | Sep 7, 8:23 pm EDT | Patrick R. O'NeilSVP, Legal and General Counsel | 1,000 | — | — | 200 | — | |
| Jul 24, 2017 MForm 4 → | Jul 26, 8:03 pm EDT | C Frank BennettSVP, Antisense Research | 10,000 | — | — | 12,250 | — | |
| Jul 20, 2017 MForm 4 → | Jul 24, 5:54 pm EDT | Stanley T CrookeChairman and CEO, Director | 11,000 | — | — | 4,904 | — | |
| Jul 17, 2017 MForm 4 → | Jul 18, 7:01 pm EDT | Stanley T CrookeChairman and CEO, Director | 16,500 | — | — | 5,904 | — | |
| Jul 3, 2017 MForm 4 → | Jul 3, 5:34 pm EDT | Stanley T CrookeChairman and CEO, Director | 16,500 | — | — | 7,404 | — | |
| Jul 1, 2017 AMForm 4 → | Jul 3, 5:33 pm EDT | Joseph H WenderDirector | 21,136 | — | — | 16,000 | — | |
| Jul 1, 2017 AMForm 4 → | Jul 3, 5:33 pm EDT | Frederick T MutoDirector | 21,136 | — | — | 16,000 | — | |
| Jul 1, 2017 AMForm 4 → | Jul 3, 5:32 pm EDT | Joseph LoscalzoDirector | 20,668 | — | — | 1,600 | — | |
| Jul 1, 2017 AMForm 4 → | Jul 3, 5:31 pm EDT | Joseph Klein IIIDirector | 21,136 | — | — | 16,000 | — | |
| Jul 1, 2017 AMForm 4 → | Jul 3, 5:31 pm EDT | Breaux CastlemanDirector | 22,073 | — | — | 16,000 | — | |
| Jul 1, 2017 AMForm 4 → | Jul 3, 5:30 pm EDT | Spencer R BerthelsenDirector | 21,136 | — | — | 16,000 | — | |
| Jun 1, 2017 MForm 4 → | Jun 2, 6:15 pm EDT | Patrick R. O'NeilSVP, Legal & General Counsel | 70 | — | — | 1,700 | — | |
| May 31, 2017 MForm 4 → | Jun 2, 6:16 pm EDT | Frederick T MutoDirector | 12,500 | — | — | 0 | — | |
| May 1, 2017 MForm 4 → | May 3, 6:01 pm EDT | Patrick R. O'NeilSVP, Legal & General Counsel | 500 | — | — | 1,770 | — | |
| Apr 25, 2017 MForm 4 → | Apr 27, 6:03 pm EDT | Stanley T CrookeChairman and CEO, Director | 16,500 | — | — | 8,904 | — | |
| Apr 24, 2017 MForm 4 → | Apr 26, 5:58 pm EDT | Patrick R. O'NeilSVP, Legal & General Counsel | 500 | — | — | 3,500 | — | |
| Apr 19, 2017 MForm 4 → | Apr 21, 5:42 pm EDT | Stanley T CrookeChairman and CEO, Director | 5,500 | — | — | 10,404 | — | |
| Apr 12, 2017 MForm 4 → | Apr 13, 7:24 pm EDT | Stanley T CrookeChairman and CEO, Director | 22,000 | — | — | 10,904 | — | |
| Mar 3, 2017 MForm 4 → | Mar 6, 7:25 pm EST | C Frank BennettSVP, Antisense Research | 5,000 | — | — | 22,250 | — | |
| Mar 2, 2017 MForm 4 → | Mar 6, 7:23 pm EST | Stanley T CrookeChairman and CEO, Director | 12,100 | — | — | 1,500 | — | |
| Mar 1, 2017 MForm 4 → | Mar 2, 7:12 pm EST | B Lynne ParshallCOO, Director | 4,625 | — | — | 7,785 | — | |
| Mar 1, 2017 MForm 4 → | Mar 2, 7:11 pm EST | Patrick R. O'NeilSVP, Legal & General Counsel | 500 | — | — | 3,926 | — | |
| Feb 24, 2017 MForm 4 → | Feb 27, 7:15 pm EST | Spencer R BerthelsenDirector | 12,500 | — | — | 0 | — | |
| Feb 6, 2017 MForm 4 → | Feb 8, 6:32 pm EST | Patrick R. O'NeilSVP, Legal & General Counsel | 500 | — | — | 4,426 | — | |
| Feb 3, 2017 MForm 4 → | Feb 3, 6:31 pm EST | Joseph LoscalzoDirector | 937 | — | — | 937 | — | |
| Jan 15, 2017 AMForm 4 → | Jan 18, 6:48 pm EST | Sarah BoyceChief Business Officer | 11,020 | — | — | 3,883 | — | |
| Jan 15, 2017 AMForm 4 → | Jan 18, 6:38 pm EST | Brett P MoniaSVP, Antisense Drug Discovery | 14,402 | — | — | 4,779 | — | |
| Jan 15, 2017 AMForm 4 → | Jan 18, 6:37 pm EST | Patrick R. O'NeilSVP, Legal & General Counsel | 13,282 | — | — | 4,779 | — | |
| Jan 15, 2017 AMForm 4 → | Jan 18, 6:37 pm EST | C Frank BennettSVP, Antisense Research | 13,732 | — | — | 4,779 | — | |
| Jan 15, 2017 AMForm 4 → | Jan 18, 6:36 pm EST | Stanley T CrookeChairman and CEO, Director | 59,694 | — | — | 999 | — | |
| Jan 15, 2017 AMForm 4 → | Jan 18, 6:36 pm EST | B Lynne ParshallCOO, Director | 35,639 | — | — | 13,443 | — | |
| Jan 15, 2017 AMForm 4 → | Jan 18, 6:35 pm EST | Elizabeth L HougenSVP, Finance & CFO | 13,351 | — | — | 4,779 | — | |
| Jan 15, 2017 AMForm 4 → | Jan 18, 6:35 pm EST | Richard S GearySVP, Development | 13,783 | — | — | 4,779 | — | |
| Jan 10, 2017 MForm 4 → | Jan 12, 6:18 pm EST | Stanley T CrookeChairman and CEO, Director | 13,200 | — | — | 2,600 | — | |
| Jan 3, 2017 AMForm 4 → | Jan 4, 6:35 pm EST | Stanley T CrookeChairman and CEO, Director | 197,870 | — | — | 3,800 | — | |
| Jan 3, 2017 AForm 4 → | Jan 4, 6:35 pm EST | Sarah BoyceChief Business Officer | 45,225 | — | — | 45,225 | — | |
| Jan 3, 2017 AForm 4 → | Jan 4, 6:34 pm EST | Brett P MoniaSVP, Antisense Drug Discovery | 48,000 | — | — | 48,000 | — | |
| Jan 3, 2017 AForm 4 → | Jan 4, 6:34 pm EST | Patrick R. O'NeilSVP, Legal & General Counsel | 45,225 | — | — | 45,225 | — | |
| Jan 3, 2017 AForm 4 → | Jan 4, 6:33 pm EST | Elizabeth L HougenSVP, Finance & CFO | 45,225 | — | — | 45,225 | — | |
| Jan 3, 2017 AForm 4 → | Jan 4, 6:32 pm EST | C Frank BennettSVP, Antisense Research | 45,225 | — | — | 45,225 | — | |
| Jan 3, 2017 AForm 4 → | Jan 4, 6:31 pm EST | B Lynne ParshallCOO, Director | 117,638 | — | — | 117,638 | — | |
| Jan 3, 2017 AForm 4 → | Jan 4, 6:30 pm EST | Richard S GearySVP, Development | 45,225 | — | — | 45,225 | — | |
| Dec 15, 2016 MForm 4 → | Dec 16, 7:21 pm EST | B Lynne ParshallCOO, Director | 4,000 | — | — | 0 | — | |
| Dec 5, 2016 MForm 4 → | Dec 7, 7:51 pm EST | Elizabeth L HougenSVP, Finance & CFO | 2,500 | — | — | 0 | — | |
| Dec 5, 2016 MForm 4 → | Dec 7, 7:27 pm EST | Patrick R. O'NeilSVP, Legal & General Counsel | 350 | — | — | 2,344 | — | |
| Dec 1, 2016 MForm 4 → | Dec 2, 6:58 pm EST | B Lynne ParshallCOO, Director | 12,500 | — | — | 12,410 | — | |
| Nov 14, 2016 MForm 4 → | Nov 16, 11:56 am EST | Elizabeth L HougenSVP, Finance & CFO | 2,500 | — | — | 2,500 | — | |
| Nov 14, 2016 MForm 4 → | Nov 14, 6:53 pm EST | Patrick R. O'NeilSVP, Legal & General Counsel | 1,000 | — | — | 2,694 | — | |
| Nov 9, 2016 MForm 4 → | Nov 14, 6:52 pm EST | Elizabeth L HougenSVP, Finance & CFO | 5,000 | — | — | 5,000 | — | late |
| Nov 9, 2016 MForm 4 → | Nov 14, 6:51 pm EST | Stanley T CrookeChairman and CEO, Director | 33,000 | — | — | 5,500 | — | late |
| Nov 9, 2016 MForm 4 → | Nov 14, 6:51 pm EST | C Frank BennettSVP, Antisense Research | 22,805 | — | — | 0 | — | late |
| Nov 7, 2016 MForm 4 → | Nov 9, 6:22 pm EST | C Frank BennettSVP, Antisense Research | 5,000 | — | — | 22,805 | — | |
| Oct 5, 2016 MForm 4 → | Oct 7, 5:49 pm EDT | Stanley T CrookeChairman and CEO, Director | 11,000 | — | — | 8,500 | — | |
| Sep 27, 2016 MForm 4 → | Sep 29, 5:05 pm EDT | Stanley T CrookeChairman and CEO, Director | 22,000 | — | — | 9,500 | — | |
| Sep 21, 2016 MForm 4 → | Sep 23, 6:31 pm EDT | Stanley T CrookeChairman and CEO, Director | 22,000 | — | — | 11,500 | — | |
| Sep 1, 2016 MForm 4 → | Sep 6, 6:52 pm EDT | B Lynne ParshallCOO, Director | 12,500 | — | — | 24,910 | — | |
| Jul 1, 2016 AMForm 4 → | Jul 6, 6:41 pm EDT | Spencer R BerthelsenDirector | 20,782 | — | — | 16,000 | — | |
| Jul 1, 2016 AMForm 4 → | Jul 6, 6:41 pm EDT | Frederick T MutoDirector | 20,782 | — | — | 16,000 | — | |
| Jul 1, 2016 AMForm 4 → | Jul 6, 6:38 pm EDT | Joseph LoscalzoDirector | 20,001 | — | — | 16,000 | — | |
| Jul 1, 2016 AMForm 4 → | Jul 6, 6:37 pm EDT | Joseph Klein IIIDirector | 20,782 | — | — | 16,000 | — | |
| Jul 1, 2016 AMForm 4 → | Jul 6, 6:37 pm EDT | Breaux CastlemanDirector | 21,407 | — | — | 16,000 | — | |
| Jul 1, 2016 AMForm 4 → | Jul 6, 6:36 pm EDT | Joseph H WenderDirector | 20,782 | — | — | 16,000 | — | |
| May 31, 2016 MForm 4 → | Jun 2, 6:25 pm EDT | Frederick T MutoDirector | 12,500 | — | — | 0 | — | |
| Apr 6, 2016 MForm 4 → | Apr 7, 6:18 pm EDT | Patrick R. O'NeilSVP, Legal & General Counsel | 1,000 | — | — | 5,101 | — | |
| Apr 6, 2016 MForm 4 → | Apr 7, 6:18 pm EDT | Stanley T CrookeChairman and CEO, Director | 11,000 | — | — | 13,500 | — | |
| Mar 31, 2016 MForm 4 → | Apr 1, 6:18 pm EDT | Stanley T CrookeChairman and CEO, Director | 11,000 | — | — | 14,500 | — | |
| Mar 23, 2016 MForm 4 → | Mar 24, 7:13 pm EDT | Patrick R. O'NeilSVP, Legal & General Counsel | 1,000 | — | — | 6,101 | — | |
| Feb 19, 2016 MForm 4 → | Feb 22, 4:10 pm EST | Spencer R BerthelsenDirector | 12,500 | — | — | 0 | — | |
| Feb 3, 2016 MForm 4 → | Feb 4, 11:54 am EST | Joseph LoscalzoDirector | 938 | — | — | 1,874 | — | |
| Jan 15, 2016 AMForm 4 → | Jan 19, 8:27 pm EST | Stanley T CrookeChairman and CEO, Director | 58,524 | — | — | 1,087 | — | |
| Jan 15, 2016 AMForm 4 → | Jan 19, 8:27 pm EST | Elizabeth L HougenSVP, Finance & CFO | 11,135 | — | — | 4,138 | — | |
| Jan 15, 2016 AMForm 4 → | Jan 19, 8:12 pm EST | Patrick R. O'NeilSVP, Legal & General Counsel | 11,066 | — | — | 3,931 | — | |
| Jan 15, 2016 AMForm 4 → | Jan 19, 8:11 pm EST | B Lynne ParshallCOO & Secretary, Director | 31,192 | — | — | 16,557 | — | |
| Jan 15, 2016 AMForm 4 → | Jan 19, 8:09 pm EST | Richard S GearySVP, Development | 11,800 | — | — | 4,138 | — | |
| Jan 15, 2016 AMForm 4 → | Jan 19, 8:09 pm EST | Brett P MoniaSVP, Antisense Drug Discovery | 11,916 | — | — | 4,552 | — | |
| Jan 15, 2016 AMForm 4 → | Jan 19, 8:08 pm EST | Sarah BoyceChief Business Officer | 7,366 | — | — | 6,562 | — | |
| Jan 15, 2016 AMForm 4 → | Jan 19, 8:08 pm EST | C Frank BennettSVP, Antisense Research | 11,668 | — | — | 3,931 | — | |
| Jan 5, 2016 MForm 4 → | Jan 7, 6:52 pm EST | Stanley T CrookeChairman and CEO, Director | 5,500 | — | — | 500 | — | |
| Jan 4, 2016 AMForm 4 → | Jan 4, 9:26 pm EST | B Lynne ParshallCOO & Secretary, Director | 108,358 | — | — | 28,545 | — | |
| Jan 4, 2016 AMForm 4 → | Jan 4, 9:25 pm EST | Patrick R. O'NeilSVP, Legal & General Counsel | 39,240 | — | — | 1,219 | — | |
| Jan 4, 2016 AForm 4 → | Jan 4, 9:24 pm EST | Brett P MoniaSVP, Antisense Drug Discovery | 38,240 | — | — | 38,240 | — | |
| Jan 4, 2016 AForm 4 → | Jan 4, 9:23 pm EST | Elizabeth L HougenSVP, Finance & CFO | 38,240 | — | — | 38,240 | — | |
| Jan 4, 2016 AForm 4 → | Jan 4, 9:23 pm EST | Richard S GearySVP, Development | 38,240 | — | — | 38,240 | — | |
| Jan 4, 2016 AMForm 4 → | Jan 4, 9:22 pm EST | Stanley T CrookeChairman and CEO, Director | 214,182 | — | — | 1,000 | — | |
| Jan 4, 2016 AForm 4 → | Jan 4, 9:21 pm EST | Sarah BoyceChief Business Officer | 31,070 | — | — | 31,070 | — | |
| Jan 4, 2016 AForm 4 → | Jan 4, 9:19 pm EST | C Frank BennettSVP, Antisense Research | 38,240 | — | — | 38,240 | — |
Filed by this entity as an insider elsewhere — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 17, 2018 JForm 4 → | Oct 18, 8:05 pm EDT | AKCEA THERAPEUTICS, INC.AKCA | 1,671,849 | — | — | 67,383,965 | — | plan? |
| Aug 3, 2018 JForm 4 → | Aug 6, 5:17 pm EDT | AKCEA THERAPEUTICS, INC.AKCA | 1,597,571 | — | — | 65,712,116 | — | plan? |
| Apr 17, 2018 PForm 4 → | Apr 19, 6:48 pm EDT | AKCEA THERAPEUTICS, INC.AKCA | 10,666,666 | $18.75 | $199,999,988 | 64,114,545 | +20.0% | plan? |
| Apr 17, 2018 JForm 4 → | Apr 19, 6:48 pm EDT | AKCEA THERAPEUTICS, INC.AKCA | 8,000,000 | — | — | 53,447,879 | — | plan? |
| Jul 19, 2017 PForm 4 → | Jul 21, 4:04 pm EDT | AKCEA THERAPEUTICS, INC.AKCA | 3,125,000 | $8.00 | $25,000,000 | 45,447,879 | +7.38% | plan? |
| Jul 19, 2017 CJForm 4 → | Jul 21, 4:04 pm EDT | AKCEA THERAPEUTICS, INC.AKCA | 42,322,879 | — | — | 42,322,879 | — | plan? |
| Jul 15, 2015 SForm 4 → | Jul 17, 6:08 pm EDT | Regulus Therapeutics Inc.RGLS | 343,133 | $10.60 | $3,636,078 | 5,173,172 | −6.22% | plan? |
| Jun 30, 2015 SForm 4 → | Jul 2, 4:28 pm EDT | Regulus Therapeutics Inc.RGLS | 13,248 | $10.79 | $143,010 | 5,516,305 | −0.24% | plan? |
| Jun 23, 2015 GForm 4 → | Jul 2, 4:28 pm EDT | Regulus Therapeutics Inc.RGLS | 13,248 | — | — | 5,529,553 | — | plan? late |
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 19, 2017 CForm 4 → | Jul 21, 4:04 pm EDT | AKCEA THERAPEUTICS, INC.AKCA | 28,884,540 | — | — | 0 | — |